Calypte raises $3m in private money:
This article was originally published in Clinica
Executive Summary
Calypte Biomedical has raised $3m following a private placement of over 16 million shares of its stock with two unnamed investors. The Lake Oswego, Oregon-based company said it will use the proceeds for general working capital purposes, as it continues the commercial roll-out of its Aware line of rapid HIV antibody tests. The firm specialises in developing tests that detect sexually transmitted diseases such as HIV, without the need for blood samples.